Table 2:
Placebo | GLC | GLP-2 | GLP-2 + GLC | SEM | P-value | |
---|---|---|---|---|---|---|
apoB48 abundance | ||||||
Time to peak (min) | 22a | 14ab | 2b | 10ab | 3.22 | 0.004 |
Maximal fold change | 1.35 | 1.19 | 1.02 | 1.31 | 0.113 | 0.201 |
apoB48 output | ||||||
Time to peak (min) | 24 | 18 | 17 | 18 | 2.87 | 0.329 |
Maximal fold change | 1.99 | 2.36 | 2.48 | 2.95 | 0.62 | 0.746 |
TG: apoB48 | ||||||
Time to peak (min) | 12.2 | 13.9 | 12.2 | 10.9 | 3.375 | 0.898 |
Maximal fold change | 1.29 | 2.73 | 1.15 | 1.73 | 0.401 | 0.056 |
Superscripts of differing letters within a row indicate significant differences as identified by Tukey separation